CD8A and neoplasm: Indeed, we were able to demonstrate the existence of functional CD4+ and CD8+ tumor-specific T cells and found a greater number of these cells when tumors were injected with NDV-αCTLA-4 or NDV-sPD-1 compared to the PBS- and NDV-GFP-treated controls.